drugset / Trial / NCT04411615

Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

NCT04411615

Unknown 30 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery

Timeline

Start
2020-07-01
Primary completion
2020-08-01
Completion
2021-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown

Indications